We are live on
!
Find out more
WF
Welch & Forbes Portfolio holdings
AUM
$8.23B
1-Year Est. Return
17.62%
This Fund
S&P 500
This Quarter
Est. Return
+3.82%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.87B
AUM Growth
-$13.1M
(-0.34%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-3.37%
Top 10 Holdings %
Top 10 Hldgs %
23.72%
Holding
372
New
16
Increased
96
Reduced
171
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$7.62M |
| 2 |
Constellation Brands
STZ
|
+$4.4M |
| 3 |
CHX
ChampionX
CHX
|
+$3.45M |
| 4 |
Stanley Black & Decker
SWK
|
+$3.4M |
| 5 |
Valero Energy
VLO
|
+$2.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$41.6M |
| 2 |
Check Point Software Technologies
CHKP
|
+$11.3M |
| 3 |
Medtronic
MDT
|
+$9.78M |
| 4 |
Franklin Resources
BEN
|
+$8.22M |
| 5 |
CELG
Celgene Corp
CELG
|
+$7.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 17.92% |
| 3 | Financials | 11.59% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Kimberly-Clark
KMB
$36.6B
| $5.01M | 0.13% |
47,566
-4,783
| -9% | -$497K |
|
|
SRCL
127
DELISTED
Stericycle Inc
SRCL
| $4.74M | 0.12% |
72,660
-28,599
| -28% | -$1.78M |
|
|
WBA
128
DELISTED
Walgreens Boots Alliance
WBA
| $4.72M | 0.12% |
78,633
-11,717
| -13% | -$754K |
|
129
WisdomTree Japan Hedged Equity Fund
DXJ
$7.13B
| $4.44M | 0.11% |
82,325
-488
| -0.6% | -$27.6K |
|
130
Tractor Supply
TSCO
$15.8B
| $4.42M | 0.11% |
289,195
-7,375
| -2% | -$103K |
|
131
General Mills
GIS
$19.4B
| $4.39M | 0.11% |
99,244
-3,896
| -4% | -$171K |
|
132
Union Pacific
UNP
$172B
| $4.37M | 0.11% |
30,836
-649
| -2% | -$90.5K |
|
133
Amazon
AMZN
$2.53T
| $4.17M | 0.11% |
49,020
+4,700
| +11% | +$373K |
|
134
Bank OZK
OZK
$5.57B
| $4.07M | 0.11% |
90,430
+34,955
| +63% | +$1.67M |
|
135
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
| $4.06M | 0.11% |
35,180
+6,095
| +21% | +$730K |
|
|
AGN
136
DELISTED
Allergan plc
AGN
| $3.88M | 0.1% |
23,274
-694
| -3% | -$111K |
|
137
Charter Communications
CHTR
$16.9B
| $3.65M | 0.09% |
12,437
-233
| -2% | -$67K |
|
138
Texas Instruments
TXN
$255B
| $3.55M | 0.09% |
32,209
-497
| -2% | -$53.8K |
|
|
CHX
139
DELISTED
ChampionX
CHX
| $3.52M | 0.09% |
+84,371
| New | +$3.45M |
|
140
Boeing
BA
$175B
| $3.51M | 0.09% |
10,459
+185
| +2% | +$63.6K |
|
141
Zimmer Biomet
ZBH
$18.4B
| $3.5M | 0.09% |
32,366
-3,194
| -9% | -$348K |
|
142
NOV
NOV
$6.88B
| $3.5M | 0.09% |
80,535
+2,285
| +3% | +$92.5K |
|
143
Progressive
PGR
$124B
| $3.13M | 0.08% |
52,862
-1,257
| -2% | -$76.9K |
|
144
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $3.05M | 0.08% |
14,932
+2,214
| +17% | +$443K |
|
145
Icon
ICLR
$12.8B
| $3.03M | 0.08% |
22,881
-369
| -2% | -$46K |
|
146
Analog Devices
ADI
$179B
| $3.03M | 0.08% |
31,565
-2,380
| -7% | -$225K |
|
147
Morningstar
MORN
$7.24B
| $3.02M | 0.08% |
23,521
-2,450
| -9% | -$280K |
|
148
Adobe
ADBE
$98.5B
| $3.01M | 0.08% |
12,351
+1,682
| +16% | +$398K |
|
149
Northrop Grumman
NOC
$76B
| $2.92M | 0.08% |
9,505
+134
| +1% | +$44.3K |
|
150
Alibaba
BABA
$279B
| $2.88M | 0.07% |
15,526
+365
| +2% | +$69.6K |
|
Similar funds
OC
LGF
CCM
CL
WJWM
WA
GGHC
CCM
Welch & Forbes's Q2 2018 Portfolio in Review
As of Q2 2018, Welch & Forbes held 372 positions worth $3.87B, down 0.34% from $3.88B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Welch & Forbes withdrew a net $131M in Q2 2018, closing 13 positions and reducing 171 holdings. Its most notable exit was Chubb, an estimated $41.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Welch & Forbes opened a new position in ChampionX worth $3.52M.
- Welch & Forbes's largest Q2 2018 buy was ChampionX: 84,371 shares worth $3.52M.
- Welch & Forbes added most to Thermo Fisher Scientific in Q2 2018, an estimated $7.62M increase.
- Welch & Forbes's biggest Q2 2018 reduction was Franklin Resources, cutting an estimated $8.22M.
- Welch & Forbes fully exited Chubb in Q2 2018, selling an estimated $41.6M.
- Welch & Forbes's ten largest holdings make up 24% of its $3.87B portfolio in Q2 2018.
- Welch & Forbes opened 16 new positions and closed 13 in Q2 2018.
- Welch & Forbes's portfolio value fell 0.34% quarter-over-quarter to $3.87B.
Based on Welch & Forbes's 13F filing for Q2 2018, filed 16 Jul 2018.